Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial
✍ Scribed by Klaus Havemann; Martin Wolf; Rolf Holle; Claus Gropp; Peter Drings; Hans-Georg Manke; Klaus Hans; Michael Schroeder; Manfred Heim; Norbert Victor; Axel Georgii; Carlos Thomas; Karl-Heinz Pflüger; Gerold Bepler
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 957 KB
- Volume
- 59
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background. Preclinical data suggested that alphainterferon (IFN) may potentiate chemotherapy cytotoxicity. Methods. A prospective multicentric randomized trial was initiated to assess the clinical benefit of adding This work was conducted by the Italian Lung Cancer Task Force (FONICAP), which carr
arino et al.' have performed a meta-analysis using data extracted M from published randomized trials comparing radiotherapy (RT) to RT plus chemotherapy (CT) in Stage IIIA and IIIB unresectable nonsmall cell lung cancer (NSCLC). They identified 14 trials published between 1980 and 1994. The odds rat
Background. For patients with Stage I11 nonsmall cell lung cancer (NSCLC), radiation is the standard treatment, but survival remains poor. The authors performed a meta-analysis study using clinical trials that evaluated combined radiotherapy plus chemotherapy versus radiotherapy alone in patients wi